Johnson & Johnson on Tuesday said first-quarter earnings rose 16%, helped by a break-up fee from its failed pact to acquire Guidant Corp. and higher sales of medical devices.
*For more on this story,
read the full Reuters article.
Johnson & Johnson on Tuesday said first-quarter earnings rose 16%, helped by a break-up fee from its failed pact to acquire Guidant Corp. and higher sales of medical devices.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99